$67.54
Value $86.6B
MDLZ and PETS stock compared: price, dividend, valuation and results, from SEC filings.
$67.54
Value $86.6B
$0.90
Value $19M
Mondelez International (MDLZ) has a market value of $86.6B and PetMed Express (PETS) $19M. Over the last year, with dividends, MDLZ moved +23.1% and PETS -55.0%. Dividend yield: MDLZ 2.99%, PETS none.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
MDLZ$86.6B
PETS$19M
MDLZ is 4,514 times PETS
Revenue, 12 months
MDLZ$39.9B
PETS$160M
MDLZ is 249 times PETS
Net income, 12 months
MDLZ$4.1B
PETS-$27M
Operating margin
MDLZ13.7%
PETS-18.0%
31.7 points apart
ROIC
MDLZ9.1%
PETS-78.7%
87.8 points apart
P/E
MDLZ21.2
PETS–
Dividend yield
MDLZ3.0%
PETS0.0%
3.0 points apart
5-year return
MDLZ+23.1%
PETS-96.6%
119.7 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
MDLZ+23.1%
PETS-96.6%
| Period | MDLZWith dividends | PETSWith dividends |
|---|---|---|
| 1 year since November 14, 2025 | +23.1%Price +18.8% | -55.0%Price -55.0% |
| 3 years since November 16, 2023 | +4.6%+1.5% a yearPrice -4.4% | -88.2%-50.9% a yearPrice -88.2% |
| 5 years since November 15, 2021 | +23.1%+4.2% a yearPrice +7.5% | -96.6%-49.1% a yearPrice -97.0% |
| 10 years since November 16, 2016 | +102.0%+7.3% a yearPrice +58.7% | -94.4%-25.1% a yearPrice -95.9% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
MDLZMondelez InternationalPETSPetMed Express
| Price | $67.54 | $0.90 |
|---|---|---|
| Market value | $86.6B | $19M |
| Enterprise value (EV) | $105B | $7.8M |
| P/E | 21.2 | – |
| P/E, 5-year median | 21.8 | – |
| P/B | 3.3 | 1.1 |
| EV/EBIT | 19.2 | – |
| Free cash flow yield | 4.2% | – |
| Revenue, 12 months | $39.9B | $160M |
|---|---|---|
| Net income, 12 months | $4.1B | -$27M |
| Free cash flow, 12 months | $3.7B | -$25M |
| Earnings per share, 12 months | $3.18 | -$1.28 |
| Revenue growth, year on year | 5.8% | -21.1% |
| Revenue growth a year, past | +7.7%over 5 years | -10.0%over 5 years |
| EPS growth a year, past | -5.2%over 5 years | – |
| Gross margin | 34.3% | 27.8% |
|---|---|---|
| Operating margin | 13.7% | -18.0% |
| Net margin | 10.2% | -17.0% |
| ROIC | 9.1% | -78.7% |
| ROE | 15.6% | -94.0% |
| Cash | $1.7B | $11M |
|---|---|---|
| Total debt | $20.6B | $291.0K |
| Net debt / EBITDA | 2.7 | – |
| Interest cover | 9.2× | – |
| Dividend yield | 3.0% | – |
|---|---|---|
| Dividend per share, 12 months | $2.02 | – |
| Dividend growth a year, past | +10.4%over 5 years | – |
| Buyback yield | 2.8% | – |
| Shareholder yield | 5.7% | – |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Mondelez International ($86.6B) is about 4,513.8 times PetMed Express ($19M), at today's prices.
Since November 16, 2016, MDLZ's price moved +58.7% and PETS's -95.9%. With dividends: MDLZ +102.0% (+7.3% a year), PETS -94.4% (-25.1% a year). Past returns do not predict future ones.
The dividend yield at today's price is 2.99% for Mondelez International and none for PetMed Express. Over the last twelve months they paid $2.02 and – per share.
Over the last twelve months, the net margin was 10.2% for Mondelez International and -17.0% for PetMed Express, and the operating margin 13.7% and -18.0%. Revenue was $39.9B and $160M.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.